TSHA-108

N/A

Report date: 2023/10/26 17:02:18

Base Information

Drug NameTSHA-108
Drug Alias NameTSHA-108
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsMetabolism, Inborn Errors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaysha Gene Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesTaysha Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsMetabolism, Inborn Errors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A